Press "Enter" to skip to content

Glenmark Pharma gets tentative nod from USFDA for acne treatment drug

Glenmark Pharmaceuticals, USA, has been granted tentative approval by the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Foam, 1 per cent, the company said in a BSE filing.

Original source:

Also Read:   World pharma supplier India restricts export of some ingredients, drugs